SKU: 4308050446
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
ahk-cu x49 Frag 176-191: Lipolytic, Osteoarthritic, vials ML:30 ml
Frag 176-191: Lipolytic, Osteoarthritic, and Oncologic Models
Compounded semaglutide represents the FDA-approved GLP-1 pathway, while 5-Amino-1MQ targets cellular metabolism directly, and AOD-9604 uses growth hormone biology for selective fat reduction
vials
ML:30 ml
These ranges come from animal-data extrapolation and informal reports, not controlled human trials, and the two routes are not directly interchangeable
US$ 20.08
US$ 20.86
US$ 25.81
